Navigation Links
Cyberonics Reports Record Fiscal 2014 Second Quarter Results
Date:11/21/2013

income and income per diluted share," commented Dan Moore, Cyberonics' President and Chief Executive Officer.  "Our U.S. sales team provided another strong performance with a record quarter in both unit sales and net product sales.  Our estimates suggest that new patient additions in absolute numbers were the highest in eight years, while estimates of replacement growth rates are consistent with those provided in our annual guidance.

"International unit sales were well ahead of the second quarter of last year, with Europe continuing to deliver unit growth in double digits.  Foreign exchange movements favorably impacted sales for the second quarter of fiscal 2014 by approximately $200,000 compared to the second quarter of fiscal 2013.  On a constant currency basis, the increase in international sales was 8.5%, with a higher proportion of our international sales coming from distributors.

"Adjusted EBITDA for the second quarter was $26 million, and our balance sheet remains healthy, with available cash and short-term investments of $123 million.

"We are particularly pleased to have delivered on one of our key product development goals for fiscal 2014 with the submission this quarter of the AspireSR generator for regulatory approval in Europe.  This regulatory filing marks an important milestone for the entire product development team.  We continued to enroll patients in the first phase of our E-37 U.S. clinical study for the AspireSR generator and expect to complete enrollment by the end of the fiscal year.

"Significant and positive product development work continued on both the Relay™ and ProGuardian™ platform technologies during the quarter, and our product development investment is likely to be higher in the third quarter as we strive to bring these products to submission-ready status.  As previously advised, we completed enrollment in the ANTHEM-HF study assessing Autonomic Regulation The
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cyberonics To Report Fiscal Year 2013 First Quarter Results And Host Conference Call On August 28, 2012
2. Cyberonics To Present At Morgan Stanley 2012 Global Healthcare Conference
3. Cyberonics To Participate In Upcoming September Investor Conferences
4. Cyberonics Announces Investment In cerbomed GmbH
5. Cyberonics To Report Fiscal Year 2013 Second Quarter Results And Host Webcast And Conference Call On November 16, 2012
6. Cyberonics To Present At The 24th Annual Piper Jaffray Healthcare Conference
7. Free Research Report on Laboratory Corp. of America Holdings, Sony Corp., Cyberonics, Inc., Olin Corp. and Deluxe Corp.
8. Cyberonics Announces Update On Hagerty Lawsuit
9. Cyberonics to Participate in Upcoming Investor Conferences
10. Cyberonics To Report Fourth Quarter And Fiscal Year 2013 Results And Host Webcast And Conference Call On June 5, 2013
11. Cyberonics To Report Fiscal Year 2014 First Quarter Results And Host Webcast And Conference Call On August 22, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market ... Scanner Industry, 2009-2019 is a professional and in-depth ... Crystallography Scanner industry . The report firstly reviews ... its classification, application and manufacturing technology. The report ... X-Ray Crystallography Scanner listing their product specification, capacity, ...
(Date:8/29/2014)... 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), ... support services for the lawfully organized cannabis industry, ... approved the Company,s name and symbol change request. ... be known as Chuma Holdings, Inc. ... merger with the Company,s wholly-owned subsidiary, Chuma Holdings, ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., a ... industry, announced that it is the first CRO on ... the company,s preclinical and early phase clinical GMP supply ... move our customers, drug candidates into the clinic more ...
... The next major personalized medicine advances will create therapies that ... health care industry to gain access, the inventor of the ... Medical Center,s Personalized Health Care National Conference ... for Systems Biology, said personalized medicine,s first "killer apps" - ...
Cached Medicine Technology:Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to ... Reduce Painkiller Overdoses (8/25), a new study found ... reduce pain have seen a significant decrease in the ... information over a ten year period, and comparing various ... able to find that there was about a 25% ...
(Date:8/29/2014)... As reported by WKMS.com in the article ... Ohio municipal court drug has come up with a new ... serves as the presiding judge in a Southeastern Ohio municipal ... addicts a medicated treatment option that can literally prevent them ... as Vivitrol, which blocks receptors in the brain that would ...
(Date:8/29/2014)... As reported by CNN.com in the article Prescription Drug ... that you need help for a prescription drug abuse problem ... fact that if you simply try to find general help ... of the information that is available online. Although the information ... still possible to get help. The statistics from SAMSHA remind ...
(Date:8/29/2014)... reported by GantDaily.com in the article NIDA Switches to ... the National Institute on Drug Abuse is taking new measures ... to social media. As NIDA currently relies on community surveillance ... the University of Maryland to create a monitoring system known ... funded by the National Institute of Health. The project is ...
(Date:8/29/2014)... USA (PRWEB) August 29, 2014 According to ... Peers, But Not Peer Pressure, Key to Prescription Drug Misuse ... the primary focus for 18-29 year olds when it comes ... that the for this age group the real problem which ... drugs, drug associations and recreational use of them to have ...
Breaking Medicine News(10 mins):Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3
... NY, October 29, 2010Women experience and interact with their natural ... in which those differences affect a woman,s sense of self, ... are explored in a thought-provoking special issue of ... Liebert, Inc. ( www.liebertpub.com ). The entire issue is available ...
... , FRIDAY, Oct. 29 (HealthDay News) -- Lack ... children with the drug-resistant staph bacteria called MRSA (methicillin-resistant ... staff need to do a better job of educating ... said the researchers at the Johns Hopkins Children Center ...
... YORK (Oct. 28, 2010) -- Scientists at Weill Cornell Medical ... and Hendra viruses, two lethal and emerging viruses for which ... could also lead to new therapies for measles, mumps and ... the prestigious journal Public Library of Science (PLoS) Pathogens ...
... - A study in the New England Journal of ... kind of lung cancer are responding positively to a treatment ... study shows 57 percent of patients with ALK-positive advanced non-small ... called crizotinib, an investigational anaplastic lymphoma kinase (ALK) inhibitor. In ...
... of Wisconsin are conducting the KAST clinical trial ... effectiveness of a new vertebral augmentation treatment (Kiva) ... osteoporosis. Sean Tutton, M.D, associate ... College, is principal interventional radiology investigator for this ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, Oct. ... the brain,s ability to detect and correct errors, such as ... , Researchers had three groups of 24 skilled typists use ... inserted typographical errors or removed them from the typed text ...
Cached Medicine News:Health News:Women's unique connection to nature is explored in special issue of Ecopsychology 2Health News:Many Parents in the Dark About Drug-Resistant Infections: Study 2Health News:Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers 2Health News:People with specific kind of lung cancer respond to new targeted treatment 2Health News:People with specific kind of lung cancer respond to new targeted treatment 3Health News:National research study to assess new treatment for painful vertebral fractures 2Health News:Brain's Error-Detection System Demystified 2
Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
Inquire...
... II (Low Melt), A low temperature ... melting temperature , Optimal for in-gel restriction ... forms a very manageable clear gel that ... Melts at approximately 65°C and remains fluid ...
... Agarose, Molecular Biology Grade, is ... of nucleic acids. It can ... fragments from 0.2 to 40 ... Agarose is tested and certified ...
Medicine Products: